Sharan Kanakiriya

NPI: 1558303347
Total Payments
$11,917
2024 Payments
$62.01
Companies
11
Transactions
40
Medicare Patients
2,401
Medicare Billing
$247,186

Payment Breakdown by Category

Other$11,418 (95.8%)
Food & Beverage$396.17 (3.3%)
Education$102.28 (0.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,418 7 95.8%
Food and Beverage $396.17 28 3.3%
Education $102.28 5 0.9%

Top Paying Companies

Company Total Records Latest Year
Bayer Healthcare Pharmaceuticals Inc. $11,627 24 $0 (2024)
Otsuka America Pharmaceutical, Inc. $74.58 2 $0 (2019)
PFIZER INC. $45.45 1 $0 (2020)
AstraZeneca Pharmaceuticals LP $41.00 3 $0 (2020)
Travere Therapeutics, Inc. $36.86 3 $0 (2024)
Relypsa, Inc. $27.79 2 $0 (2019)
Vifor Pharma, Inc. $14.38 1 $0 (2022)
Horizon Therapeutics plc $12.91 1 $0 (2023)
Novartis Pharmaceuticals Corporation $12.83 1 $0 (2019)
Daiichi Sankyo Inc. $12.68 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $62.01 4 Travere Therapeutics, Inc. ($33.78)
2023 $2,370 14 Bayer Healthcare Pharmaceuticals Inc. ($2,354)
2022 $9,242 10 Bayer HealthCare Pharmaceuticals Inc. ($9,228)
2021 $16.58 1 Bayer HealthCare Pharmaceuticals Inc. ($16.58)
2020 $57.18 2 PFIZER INC. ($45.45)
2019 $156.00 8 Otsuka America Pharmaceutical, Inc. ($74.58)
2017 $12.68 1 Daiichi Sankyo Inc. ($12.68)

All Payment Transactions

40 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/19/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $14.11 General
Category: Cardio-renal
10/29/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $14.12 General
Category: Cardio-renal
04/30/2024 Travere Therapeutics, Inc. Education In-kind items and services $16.89 General
03/12/2024 Travere Therapeutics, Inc. Education In-kind items and services $16.89 General
12/15/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $19.78 General
Category: Cardio-renal
11/29/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $8.41 General
Category: Cardio-renal
11/07/2023 Travere Therapeutics, Inc. Education In-kind items and services $3.08 General
09/30/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $18.75 General
Category: Cardio-renal
09/01/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $18.97 General
Category: Cardio-renal
08/04/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $7.30 General
Category: Cardio-renal
06/21/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $4.34 General
Category: Cardio-renal
05/16/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,230.00 General
Category: Cardio-renal
04/22/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $20.20 General
Category: Cardio-renal
04/19/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $7.08 General
Category: Cardio-renal
03/14/2023 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $12.91 General
Category: KRYSTEXXA
02/20/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $5.99 General
Category: Cardio-renal
01/31/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $7.21 General
Category: Cardio-renal
01/17/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $6.43 General
Category: Cardio-renal
12/08/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,230.00 General
Category: Cardio-renal
12/07/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $34.66 General
Category: Cardio-renal
11/10/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,230.00 General
Category: Cardio-renal
11/10/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,805.00 General
Category: Cardio-renal
08/16/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $892.00 General
Category: Cardio-renal
08/02/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $23.80 General
Category: Cardio-renal
08/02/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $21.94 General
Category: Cardio-renal

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 543 764 $154,673 $62,410
2022 6 661 926 $181,090 $70,783
2021 6 599 922 $174,582 $72,021
2020 6 598 780 $113,174 $41,972
Total Patients
2,401
Total Services
3,392
Medicare Billing
$247,186
Procedure Codes
24

All Medicare Procedures & Services

24 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 301 501 $101,202 $42,488 42.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 135 135 $41,850 $14,810 35.4%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 18 18 $4,716 $1,738 36.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 24 25 $3,425 $1,658 48.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 13 20 $2,760 $1,177 42.7%
36415 Insertion of needle into vein for collection of blood sample Office 2023 52 65 $720.00 $538.63 74.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 362 595 $120,190 $49,161 40.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 161 161 $49,910 $17,275 34.6%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 14 21 $5,502 $2,098 38.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 22 22 $3,014 $1,364 45.3%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 11 11 $1,430 $541.94 37.9%
36415 Insertion of needle into vein for collection of blood sample Office 2022 91 116 $1,044 $343.62 32.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 290 581 $117,362 $50,158 42.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 170 170 $52,700 $20,112 38.2%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 13 13 $1,690 $707.07 41.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 11 11 $1,507 $619.02 41.1%
36415 Insertion of needle into vein for collection of blood sample Office 2021 102 134 $1,206 $395.75 32.8%
81003 Automated urinalysis test Office 2021 13 13 $117.00 $29.25 25.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 173 295 $59,590 $21,420 35.9%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 155 155 $48,050 $18,223 37.9%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 14 16 $1,172 $840.06 71.7%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 12 12 $1,644 $679.56 41.3%
36415 Insertion of needle into vein for collection of blood sample Office 2020 123 181 $1,629 $537.96 33.0%
81003 Automated urinalysis test Office 2020 121 121 $1,089 $270.60 24.8%

About Sharan Kanakiriya

Sharan Kanakiriya is a Nephrology healthcare provider based in Kingsport, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558303347.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sharan Kanakiriya has received a total of $11,917 in payments from pharmaceutical and medical device companies, with $62.01 received in 2024. These payments were reported across 40 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,418).

As a Medicare-enrolled provider, Kanakiriya has provided services to 2,401 Medicare beneficiaries, totaling 3,392 services with total Medicare billing of $247,186. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Other Specialties Nephrology
  • Location Kingsport, TN
  • Active Since 06/13/2006
  • Last Updated 01/16/2019
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • NPI Number 1558303347

Products in Payments

  • Kerendia (Drug) $11,627
  • SAMSCA (Drug) $74.58
  • PREVNAR 13 (Biological) $45.45
  • LOKELMA (Drug) $41.00
  • Veltassa (Drug) $27.79
  • KRYSTEXXA (Biological) $12.91
  • ENTRESTO (Drug) $12.83
  • Movantik (Drug) $12.68
  • Aimovig (Biological) $11.53

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Kingsport